Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

2 Oct 2019 16:12

RNS Number : 5695O
Synectics PLC
02 October 2019
Β 

Synectics plc

("Synectics" or the "Company")

Β 

Director/PDMR dealings

Β 

2 October 2019

Β 

HMRC Approved Employee Share Acquisition Plan ("ESAP")

Β 

Synectics (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, has been notified that the Trustee of the ESAP purchased on 1 October 2019 9,279 ordinary shares of 20 pence each in the Company ("Shares") at Β£1.53 per Share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2019.

Β 

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of Shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance the share price used for the allocation of the number of Shares for ESAP purposes was the price per Share on the date of purchase.

Β 

The Trustee also reinvested the Company's interim dividend paid to shareholders on 20 September 2019 and purchased on 1 October 2019 511 Shares at Β£1.53 per Share in accordance with the ESAP's rules.

Β 

As a result of these purchases, the Company has been notified that Paul Webb, Chief Executive Director, has acquired an interest in 652 Shares and that Greg Alcorn, a PDMR of the Company, has acquired an interest in 604 Shares.

Β 

Performance Share Plan ("PSP")

Β 

The Company has also been notified that on 1 October 2019, David Gavin, a PDMR of the Company, exercised options over Shares which had previously vested under the performance criteria of the PSP and sold the Shares at a price of Β£X per Share, as follows:

Β 

Name

Position

Status

PSP options exercised

Shares retained in own name

Shares sold

David Gavin

General Manager, Synectic Systems Group

PDMR

10,000

-

10,000

Β 

Full details of the PSP are set out in the Company's Annual Report for the year ended 30 November 2018.

Β 

Interests in Shares

Β 

Following these transactions, the interests of Paul Webb, Greg Alcorn and David Gavin in Shares are as follows:

Β 

Name

Shares Held

Interest in Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

52,115

248,149

300,264

1.69

Greg Alcorn

0

12,477

12,477

0.07

David Gavin

0

2,000

2,000

0.01

Β 

Β 

For further information, please contact:

Β 

Synectics plc

Claire Stewart, Company Secretary

Tel: +44(0)Β 1527 850 080

Β 

Shore CapitalTom Griffiths / Henry WillcocksTel: +44 (0) 20 7408 4050

Β 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

Β Β 1

Β 

Details of the person discharging managerial responsibilities / person closely associatedΒ 

a)

Β 

NamesΒ 

Paul Webb

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

Director

b)

Β 

Initial notification /AmendmentΒ 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitorΒ 

a)

Β 

NameΒ 

Synectics plc

b)

Β 

LEI

213800C1F7YZH96U2Z49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary Shares of 20p each

b)

Identification codeΒ 

Β 

GB0007156838

c)

Β 

Nature of the transactionΒ 

Β 

Purchase (by employee share acquisition plan)

d)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

153p

652 shares

d)

Β 

Aggregated informationΒ 

- Aggregated volume

- Price

Β 

n/a

Β 

e)

Β 

Date of the transactionΒ 

01 October 2019

f)

Β 

Place of the transaction

London Stock Exchange (XLON)

Β 

Β Β 1

Β 

Details of the person discharging managerial responsibilities / person closely associatedΒ 

a)

Β 

NamesΒ 

Greg Alcorn

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

PDMR

b)

Β 

Initial notification /AmendmentΒ 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitorΒ 

a)

Β 

NameΒ 

Synectics plc

b)

Β 

LEI

213800C1F7YZH96U2Z49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary Shares of 20p each

b)

Identification codeΒ 

Β 

GB0007156838

c)

Β 

Nature of the transactionΒ 

Β 

Purchase (by employee share acquisition plan)

d)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

153p

604 shares

d)

Β 

Aggregated informationΒ 

- Aggregated volume

- Price

Β 

n/a

e)

Β 

Date of the transactionΒ 

01 October 2019

f)

Β 

Place of the transaction

London Stock Exchange (XLON)

Β 

Β 

Β Β 1

Β 

Details of the person discharging managerial responsibilities / person closely associatedΒ 

a)

Β 

NamesΒ 

David Gavin

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

PDMR

b)

Β 

Initial notification /AmendmentΒ 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitorΒ 

a)

Β 

NameΒ 

Synectics plc

b)

Β 

LEI

213800C1F7YZH96U2Z49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary Shares of 20p each

b)

Identification codeΒ 

Β 

GB0007156838

c)

Β 

Nature of the transactionΒ 

Β 

Exercise of options and subsequent on-market sale of shares

d)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil (exercise price)

153p (sale price)

10,000 shares

d)

Β 

Aggregated informationΒ 

- Aggregated volume

- Price

Β 

n/a

e)

Β 

Date of the transactionΒ 

01 October 2019

f)

Β 

Place of the transaction

London Stock Exchange (XLON)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHEASEAEEPNFFF
Date   Source Headline
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update
5th Dec 20247:00 amRNS$2.7 million Contract Awards
27th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.